Credentials: Identifier: NPI 1821059700 · License: LA
Rheumatology
Internal Medicine
Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)
Annals of the Rheumatic Diseases · 2016
A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional…
Annals of the Rheumatic Diseases · 2014
Charles Ludivico
2 papers
Georgia Roane